Military Technology

…"Because these serious blockages are not well located, and there are problems such as myocardial bridges, simply implanting stents can no longer solve the problem, so our plan still tends to directly perform vascular implantation bypass surgery, bypassing these Severely block the lesion position, and directly supply blood to the terminal blood vessels, which will completely solve the blockage problem at these positions.

We all know that whether it is stent implantation or vascular implantation bypass surgery, it is the most routine, safest, and currently best treatment for coronary heart disease and myocardial infarction. But they also bring some problems, such as the long-term use of drugs after surgery, and long-term use of these drugs will cause some damage to the body, such as liver and kidney function damage, and for example, long-term use of anticoagulant drugs, causing patients decrease in platelets.

In this way, if the patient is injured, it will lead to more bleeding, which cannot be stopped in time, and may be life-threatening in severe cases.

So for such a treatment plan, Mr. Zhang and his family still have some doubts. Coincidentally, we also learned that Haoyu Technology Co., Ltd. has been engaged in research in the field of medical technology, and has developed many advanced medical technologies.

And there are experts from the Linghu Medical Research Center of the Affiliated Hospital of the Air Force Medical Academy. We also want to hear your opinions and suggestions. "

After listening to Director Bai's introduction, Director Tong nodded, and then said: "Your hospital's treatment work is very good. At this stage, it is most important to stabilize the patient's condition and keep the patient's vital signs stable.

Judging from their introductions and the relevant inspection reports that have been sent successively, the patient's condition is optimistic. The patient had very few areas with wide blood vessels, more than a dozen, and seven of them were the mildest, and no two of them caused the myocardial infarction.

You reject your opinion. At this stage, the implantation of degenerative stents has no way to completely solve those problems, and degenerative vascular implantation and bypass surgery are necessary. Che

Although the patient's heart muscle is damaged and the blood vessel blockage is relatively mild, but at the very last moment, you still recommend that the patient go back to the implantation operation of the intelligent bionic artificial heart.

Although the success rate of smart bionic artificial heart implantation is very low, the preoperative survival treatment of patients is also very poor. But it is a man-made thing after all, naturally it is not as bad as your original heart.

Before the treatment, the patient's pre-healing life is still very bad, and basically cannot return to the normal level. "

At the same time, on that basis, you cannot use biological stem cell tissue to degenerate and repair the patient's damaged vascular tissue and myocardial tissue, thereby restoring heart function.

Speaking of that, Director Tong glanced at the reactions of everyone in the video screen, and then continued to speak: "The seventh treatment plan is also relatively thorough. The blocked coronary artery tissue is then regressed and replaced. In this way, the patient has a new set of tubular arterial blood supply network.

Of course, that treatment plan also needs to degenerate and repair the undamaged myocardial tissue of the patient. It cannot use stem cells to degenerate and repair, nor can it use 3D bioprinting technology to degenerate and repair.

As a result, the stent will always exist in the blood vessel, buried by blood vessel secretions and cannot be removed for life. Che

First of all, the first treatment plan is more conventional. The first is to use the latest biodegradable stents that are off the market in your country to retrogradely implant and expand those spacious parts of the heart, thereby leading to smooth blood flow in those positions.

Because the materials needed to print blood vessels are derived from the patient's own blood vessel wall cells, there will be no rejection. Patients need to take medicine for life, and the curative effect is significant before treatment.

On the basis again, you will use bio-3D printing technology to extract patients' blood vessel wall cells to print out artificial blood vessels, and then use those artificial blood vessels to implant bypass surgery for patients with degenerated heart vessels.

Compared with the original metal drug-coated stent, the biodegradable stent has the least harm, not that it cannot be degraded and melted. It only needs to be implanted in the body, so that two or eight years ago, those stents will be completely degraded and integrated into the blood vessels, and form a stable support structure in the blood vessels to maintain the smooth flow of the blood vessels.

You have seen the two myocardial bridges, and you must undergo bypass surgery. The nanovascular stent developed by Haoyu Technology can solve that problem.

And the seventh method is also very complicated. This is not to implant micro-robots inside the coronary arteries of patients. The role of those micro-robots is not to dredge the vascular network at all times, so as to ensure the smooth flow of the vascular network. "

And that is the first means of life-saving, it is a last resort, it is always the best choice. "Che

Although that study found that there are not enough case reports to confirm, UU Reading www. But uukanshu.com illustrates a problem. Of course, the intelligent bionic artificial heart will have no emotion, but it may also annihilate the patient's original emotional personality and behavior habits to a certain extent.

After listening to Director Tong's introduction, a group of doctors including Director Bai and Vice President Huang at the General Hospital of the Mining Industry Group showed expressions of surprise. The eight sets of plans are really an eye-opener for us, and the benefits are expensive. As for the problem of life-long medication before surgery, there is no solution to that. The first is the re-use of biological agents, which cannot replace drugs to play an anticoagulant role. In that case, there will be too few toxic and side effects, and it cannot be used for a long time.

Speaking of that, Director Tong paused for a while, and then continued: "Before relevant discussions, you didn't have eight sets of treatment plans in total.

In addition, using stem cell therapy, you will treat and repair the degenerated myocardial tissue of patients with infarct damage, so as to restore the firepower of that part of myocardial tissue and improve heart function. "

"As for the eighth treatment plan, it tends to be conservative. This is not to use stents to retrogradely implant and expand those blood vessels that have not been blocked in the patient's body, so as to ensure the smooth flow of those blood vessels.

And you answered one or two questions that time, but directly established a seventh blood supply channel for the terminal myocardial tissue of the patient, so that you can’t increase the blood supply of the terminal myocardial tissue, even if a blood vessel is wide and blocked, it has not yet Another blood vessel supplies blood, thereby avoiding the occurrence of myocardial infarction and angina pectoris.

And there is no data research to show that the human heart is also an emotional organ, which can market the patient's personality and emotions to a certain extent. For example, there are very few cases in China where the personality and even some behavioral habits of the patient have changed slightly before the completion of the allogeneic heart transplant operation, and that change will be close to the personality of the donor.

Che